Expression of rabies virus glycoprotein from a recombinant vaccinia virus.
about
Vaccinia recombinant virus expressing the rabies virus glycoprotein: safety and efficacy trials in Canadian wildlife.Cyp7b, a novel brain cytochrome P450, catalyzes the synthesis of neurosteroids 7alpha-hydroxy dehydroepiandrosterone and 7alpha-hydroxy pregnenoloneFunctional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomainThe transmembrane domain of hepatitis C virus glycoprotein E1 is a signal for static retention in the endoplasmic reticulum.A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2.Involvement of endoplasmic reticulum chaperones in the folding of hepatitis C virus glycoproteinsCharged residues in the transmembrane domains of hepatitis C virus glycoproteins play a major role in the processing, subcellular localization, and assembly of these envelope proteinsSubcellular Localization and Topology of the p7 Polypeptide of Hepatitis C VirusRole of the transmembrane domains of prM and E proteins in the formation of yellow fever virus envelope.Fusion function of the Semliki Forest virus spike is activated by proteolytic cleavage of the envelope glycoprotein precursor p62Induction of protective immunity in animals vaccinated with recombinant vaccinia viruses that express PreM and E glycoproteins of Japanese encephalitis virusThe transmembrane domains of hepatitis C virus envelope glycoproteins E1 and E2 play a major role in heterodimerizationNovel Approaches to the Prevention and Treatment of Rabies1H-NMR-based profiling of organic components in leachate from animal carcasses disposal site with time.Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion proteinVaccinia virus vectors with an inactivated gamma interferon receptor homolog gene (B8R) are attenuated In vivo without a concomitant reduction in immunogenicityInduction of hepatitis C virus E1 envelope protein-specific immune response can be enhanced by mutation of N-glycosylation sitesImmune response in skunks to a vaccinia virus recombinant expressing the rabies virus glycoprotein.Studies of ERA/BHK-21 rabies vaccine in skunks and miceLong-term sterilizing immunity to rinderpest in cattle vaccinated with a recombinant vaccinia virus expressing high levels of the fusion and hemagglutinin glycoproteinsRaccoon poxvirus recombinants expressing the rabies virus nucleoprotein protect mice against lethal rabies virus infectionVaccinia virus vectors: new strategies for producing recombinant vaccines.Molecular characterization of a 23-kilodalton major antigen secreted by Toxoplasma gondii.Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection.Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector.Applications of pox virus vectors to vaccination: an update.New hepatitis B vaccines.Recombinant rabies viruses expressing GM-CSF or flagellin are effective vaccines for both intramuscular and oral immunizations.Targeting vaccinia virus-expressed secretory beta subunit of human chorionic gonadotropin to the cell surface induces antibodies.Expression of the major glycoprotein G of human respiratory syncytial virus from recombinant vaccinia virus vectors.Spatio-temporal Use of Oral Rabies Vaccines in Fox Rabies Elimination Programmes in Europe.Vaccinia virus infection of mature dendritic cells results in activation of virus-specific naïve CD8+ T cells: a potential mechanism for direct presentation.Protection against myxomatosis and rabbit viral hemorrhagic disease with recombinant myxoma viruses expressing rabbit hemorrhagic disease virus capsid protein.In vitro permissivity of bovine cells for wild-type and vaccinal myxoma virus strains.Vaccinia Virus Immunomodulator A46: A Lipid and Protein-Binding Scaffold for Sequestering Host TIR-Domain ProteinsPriming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria.A vaccinia virus renaissance: new vaccine and immunotherapeutic uses after smallpox eradication.The development and use of a vaccinia-rabies recombinant oral vaccine for the control of wildlife rabies; a link between Jenner and Pasteur.Targeting of frog prodermorphin to the regulated secretory pathway by fusion to proenkephalin.A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein.
P2860
Q24535640-129BC124-E6DF-43AA-B40F-0FE93E316BB4Q24643917-AEDB157A-7D6D-4462-86FA-9A17F2AC374FQ24645233-617698E3-3ED2-432F-8FC3-1DFDC157EDA1Q27469349-15E0F4F7-B71D-4F06-B41C-D54CEFEC5607Q27469530-694E5F3A-A9D0-4F7C-86FF-AE69FDCBA27BQ27469541-A21C6B10-7440-48D7-8A46-FE83054C3BA9Q27469653-41C1B2F4-0121-4C36-B4B1-68C2303AC17AQ27472868-C96EB74B-694A-4F36-ABD9-D5AB2CE97412Q27473078-72A0CBC4-1F31-4FE5-83F5-6410D6C2E32FQ27486570-44B970F4-8900-4831-9755-D8E2AB51AA22Q27486585-40B2BF49-47B4-4370-99D3-3FC197334971Q27622511-9D433356-7919-420F-A83D-7E8014379E55Q28818601-3E66C888-5074-4D31-A3CB-D5AB568C192AQ30819123-AA95E1FC-1876-400E-96A5-19C05A1FF09FQ33554501-644AE17B-083A-4053-9BED-B3EF262E1242Q33834391-835F3200-688A-4F2E-9A97-00EFC2C51B40Q33870023-FEBAC47A-ACB9-4103-9F79-2FBA8DD45AE0Q34080569-5D32A67B-45BE-42F9-B3F5-583C307E65F5Q34080720-7C993F43-7AFA-4FCE-B14A-76BBDF48FBF0Q34106038-D7ACE367-31AA-4F35-BBA3-E234A847D422Q34106638-5D9C7406-0B0A-46B6-90D0-C1E924567890Q34211635-047D8530-A2DE-4FF4-B048-D2C2ADEDB127Q34308254-D9A63B99-ED57-4ADA-BA59-5665A2BE990CQ34340404-CB2B1409-60BD-48B7-8299-4509E157A5BFQ34350358-080AE7AE-7FD2-4DFA-8AFC-9CCFD2FCC4A5Q34403246-CBE2CCF5-D700-4A4A-BBC3-AC479503A431Q34490083-E6169535-C0FD-41EE-BF7D-BD8A2E6E6544Q34735086-E8FBAF51-154A-4FBD-9501-179E7750492AQ35458285-56BDE71D-D22A-47AF-97E7-1491A05C311FQ35585367-C76C75C3-7D9F-4EA5-BD91-7C2836D5241EQ35747805-6382C713-90A2-47CA-AF8A-ED89BFC4A39DQ35774599-005159D6-0FA3-4996-B8F3-EDD91BA07F23Q35865836-2F515A44-1430-4D08-87AE-C3A6F5DD6BE8Q36099577-CB570B75-8DC7-4BC6-A1EC-61DEA0E6B466Q36223863-BC2130E0-B0DF-420E-9880-7FD63C8EF9AAQ36343961-6E42E6ED-2814-44ED-8E92-0087FB7048BEQ36391900-3DA81C36-DD92-4519-99B0-34CA590C508CQ36504012-3A476DD1-9FF6-4771-8AA4-923D307AD52BQ36530300-1B8EC059-8DA1-48E3-B525-807C34512A64Q36559952-6BA9C10B-632E-47AC-982B-5A11EEE9FC2F
P2860
Expression of rabies virus glycoprotein from a recombinant vaccinia virus.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh-hant
name
Expression of rabies virus glycoprotein from a recombinant vaccinia virus.
@en
Expression of rabies virus glycoprotein from a recombinant vaccinia virus.
@nl
type
label
Expression of rabies virus glycoprotein from a recombinant vaccinia virus.
@en
Expression of rabies virus glycoprotein from a recombinant vaccinia virus.
@nl
prefLabel
Expression of rabies virus glycoprotein from a recombinant vaccinia virus.
@en
Expression of rabies virus glycoprotein from a recombinant vaccinia virus.
@nl
P2093
P2860
P356
P1433
P1476
Expression of rabies virus glycoprotein from a recombinant vaccinia virus.
@en
P2093
Drillien R
Koprowski H
P2860
P2888
P304
P356
10.1038/312163A0
P407
P577
1984-11-01T00:00:00Z
P6179
1035720437